Disorders of Lipoprotein Metabolism
- ACC: Treat-to-Target LDL-C Strategy Noninferior to High-Intensity Statins
- Lipid Profiles Altered in People With Severe Mental Illness
- Elevated Lipoprotein(a) and Familial Hypercholesterolemia Tied to MI, ASCVD Risk
- Pitavastatin Plus Ezetimibe Better Than Either Agent Alone in Lowering LDL-C
- Metabolites Related to Diet Correlate With Cognitive Function in Older Adults
- Plasma Insulin May Have Role in Lipid, Lipoprotein Metabolism
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
